Latest Cost Reduction Initiatives News

ClearVue Technologies has announced a comprehensive strategic reset following a Kidder Williams review, including a refreshed board, significant cost savings, and a renewed focus on growth markets in Australia, Asia, and the Middle East.

Coventry Group reports a challenging FY25 with a statutory loss driven by ERP implementation costs and asset impairments, while setting ambitious EBITDA targets for FY26 under refreshed leadership.

AVADA Group Limited reported a revenue decline and a $9.7 million impairment on its New Zealand operations in FY25, while completing Phase 1 of its business transformation including ERP implementation and operational consolidation.

Environmental Clean Technologies Limited reported a $3.52 million net loss for FY2025, marking a modest 5% improvement, while making significant progress in commercialising its COLDry fertiliser technology and securing over $1.7 million in new capital.

DGL Group reported a 4% revenue increase to $481.5 million in FY25, but underlying profits took a hit due to operational losses and restructuring costs. The company is investing heavily in growth and system integration to drive future efficiency.

MedAdvisor reported a 36% revenue drop in FY25, driven by US health program setbacks, and sold its ANZ business to focus on restructuring its US operations.

Percheron Therapeutics posted a 25% increase in net loss for FY2025 amid termination of its Duchenne Muscular Dystrophy programs. The company pivots strategically to oncology with the in-licensing of HMBD-002, a monoclonal antibody targeting VISTA, aiming to initiate Phase II trials in 2026.

FINEOS Corporation delivered solid first-half results with revenue growth and improved profitability, while navigating currency challenges that temper full-year guidance.

DXN Limited reported a 49% surge in revenue to $16 million for FY25, driven by strong modular data centre contracts and a new Data Centre as a Service division, despite a slight increase in net loss to $2.31 million.

Ramsay Health Care posted solid revenue growth driven by its Australian and UK hospital businesses, despite a significant impairment charge impacting net profit. The group advances a multi-year transformation focusing on operational efficiency and capital discipline.

Eildon Capital Group reported a $5.7 million net loss in FY25, weighed down by $8 million in one-off charges, while simplifying its portfolio and entering a new joint venture in North Queensland.

NZME Limited reported a 3.1% revenue decline for H1 2025 but delivered a 12% rise in operating EBITDA, driven by digital growth and cost efficiencies. The company declared a 3 cent interim dividend amid ongoing economic challenges.